ALKS vs CLX · P/E 14, rev $1.56B vs P/E 15, rev $7.10B
Alkermes Plc (ALKS) versus The Clorox Company (CLX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
The Clorox Company (CLX) is a household & personal products company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Not investment advice. Open the ALKS and CLX stock pages for the full models.
Not investment advice.